![]() |
|
|
Vol. 30, Issue 1, 4-6, January 2002
| |
Abstract |
|---|
|
|
|---|
The expression levels of mRNAs for MDR1 (P-glycoprotein), multidrug resistance-associated proteins (MRP1, MRP2), and cytochrome P450 3A (CYP3A) in Caco-2 cells were quantitatively compared with those in human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Caco-2 cells (passages 36-88) were kindly supplied by several laboratories in Japan. Human duodenal enterocytes were obtained from five healthy male volunteers. Normal colorectal tissues and colorectal adenocarcinomas were simultaneously obtained from seven patients with primary colorectal adenocarcinoma. MDR1, MRP1, MRP2, and CYP3A mRNA levels were determined by real-time quantitative polymerase chain reactions (PCR). Relative concentrations of mRNAs for target proteins (MDR1, MRP1, MRP2, and CYP3A) and glyceraldehyde-3-phosphate dehydrogenase in Caco-2 cells were 1.00 ± 0.15, 1.02 ± 0.06, 0.94 ± 0.10, and 0.68 ±0.60, respectively, and those in human enterocytes were about 12-, 3-, 7-, and 8000-fold higher than in the Caco-2 cells, respectively. In contrast, MDR1, MRP1, and CYP3A mRNA levels in Caco-2 cells were comparable to those in normal colorectal tissue and colorectal adenocarcinoma.
| |
Introduction |
|---|
|
|
|---|
Recent
technological innovations in drug discovery (i.e., combinatorial
chemistry and high-throughput screening for pharmacological activity)
have enabled us to produce large numbers of potentially useful
candidate drugs within a week, and the rapid assessment of their
pharmacokinetic and toxicological properties, especially oral
absorption, has become the bottleneck in drug development (Rodrigues, 1997
; Fernandes, 1998
; Tarbit and Berman, 1998
). Over the last few decades, a correlation between intestinal epithelial cell
permeability and the overall intestinal absorption has been demonstrated, and this has prompted us to use intestinal epithelial cell lines and to conduct in vitro transport studies (Boulenc, 1997
).
Among the large number of established cell lines, the Caco-2 cell line
obtained from human colorectal cancer is the most useful for such
studies since it is capable of morphological and biochemical differentiation in vitro to form intestinal epithelium under normal culture conditions (Pinto et al., 1983
; Hidalgo and Li, 1996
; Artursson
and Borchardt, 1997
; Boulenc, 1997
; Watkins, 1997
; Milovic et al.,
1998
). Caco-2 cells express several markers and drug-metabolizing enzymes, and several transporters were found in human enterocytes, including cytochrome P450 3A (CYP3A) and P-glycoprotein (MDR1), which have recently attracted a great deal of attention due to their
barrier function against xenobiotics (Hidalgo and Li, 1996
; Watkins,
1997
). Recently, the contribution of the multidrug
resistance-associated protein (MRP1) family to
drug extrusion has also been demonstrated using Caco-2 cells (Hirohashi
et al., 2000
). Thus, the Caco-2 system has been shown to be useful for
evaluation of the transport mechanism in addition (Hidalgo and Li,
1996
; Artursson and Borchardt, 1997
; Boulenc, 1997
; Watkins, 1997
).
However, claims have sometimes been made concerning the
essential characteristics of tumor cells (Milovic et al., 1998
)
that
these cells have a lower metabolic capacity than human enterocytes
(Hidalgo and Li, 1996
; Schmiedlin-Ren et al., 1997
) and show
alterations in expression levels of oral drug absorption-related
proteins during culture and passage (Pinto et al., 1983
; Hidalgo and
Li, 1996
). In this study, mRNA levels of MDR1, MRP1, MRP2, and CYP3A in
Caco-2 cell lines were quantitatively compared with those in human
duodenal enterocytes, normal colorectal tissues, and colorectal
adenocarcinomas by means of the real-time quantitative reverse
transcription-polymerase chain reaction (RT-PCR) (Gibson et al., 1996
;
Heid et al., 1996
).
| |
Materials and Methods |
|---|
|
|
|---|
Caco-2 Cell Lines and Cell Culture.
Caco-2 cells (passage 47) obtained from the RIKEN cell bank (RIKEN
RCB0988; Saitama, Japan) were used as the authentic standard in each
run of the assay since they were demonstrated to express sufficient
levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), MDR1, MRP1,
MRP2, and CYP3A mRNA. Caco-2 cells (passages 36-88) were also kindly
supplied by several laboratories in Japan. Caco-2 cells were grown in
complete medium consisting of Dulbecco's modified Eagle's medium
(Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum
(Hyclone Laboratories, Logan, UT), 0.1 mM minimal essential
medium nonessential amino acids (Invitrogen), 2 mM
L-glutamine (Invitrogen), 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen) in an atmosphere of 95% air and 5%
CO2 at 37°C (Tsuji et al., 1994
). The cells
were subcultured every 5 to 7 days using 0.02% EDTA and 0.05%
trypsin. The assay was conducted 5 to 7 days after seeding of 1 × 105 cells in 10 ml of complete culture medium in
25-cm2 culture flasks (Nunclon flasks; Nalge Nunc
International, Rochester, NY).
Human Duodenal Enterocytes, Normal Colorectal Tissues, and
Colorectal Adenocarcinomas.
Duodenal enterocytes were obtained as proximal small-bowel mucosal
biopsy samples from five healthy Japanese male volunteers ranging in
age from 27 to 39 years old. The subjects took no medications and had
no significant health problems. After fasting overnight, the mucosal
biopsy samples were obtained by upper-intestinal endoscopy from each
subject and were immediately snap-frozen and stored at
80°C.
Colorectal adenocarcinomas were obtained as surgical samples from seven
patients with primary colorectal adenocarcinoma diagnosed at Kobe
University Hospital (four men and three women; age range, 70-80
years). Normal colorectal tissues were simultaneously taken from the
resected bowel specimens but were from regions well away from the
tumor. Normal colorectal tissue and adenocarcinoma samples were
obtained immediately after resection, and they were quickly stripped of
connective tissue, snap-frozen, and stored at
80°C until
processing. Informed consent was obtained from all subjects before
their participation in the study. The protocol was approved by the
Institutional Review Broad of Kobe University Hospital (Kobe
University, Japan).
RNA Extraction and RT. Total RNA was extracted from confluent monolayers of Caco-2 cell lines and tissue samples using an RNeasy mini-kit (QUIAGEN, Hilden, Germany) and an RNase-free DNase set (QUIAGEN). The RT reaction was conducted in 20 µl of two-step RT reaction mix containing 4 µl of the extracted total RNA (2 µg/ml), 1× TaqMan RT buffer, 5.5 mM MgCl2, 500 µM dATP, 500 µM dGTP, 500 µM dCTP, 500 µM dUTP, 2.5 µM random hexamer, 0.4 U/µl of RNase inhibitor, and 1.25 U/µl MultiScribe reverse transcriptase (Applied Biosystems, Foster City, CA). The mixture was incubated at 25°C for 10 min and subsequently at 48°C for 30 min. RT reaction was terminated by heating at 95°C for 5 min, followed by cooling at 4°C for 5 min, giving the RT product.
Real-Time Quantitative PCR.
Primer pairs and TaqMan probes for MDR1, MRP1, MRP2, and CYP3A mRNA
were designed using the Primer Express 1.0 program (Applied Biosystems)
(Table 1). Primers and the TaqMan probe
for GAPDH were purchased from Applied Biosystems (TaqMan GAPDH control
reagent kit). The principle of real-time quantitative PCR has been
described elsewhere (Gibson et al., 1996
; Heid et al., 1996
; Yajima et
al., 1998
; Latil et al., 2000
). The 25 µl of reaction mixtures
contained 1× TaqMan buffer A, 5.5 mM
MgCl2, 400 µM dUTP, 200 µM dATP, 200 µM
dCTP, 200 µM dGTP, 0.01 U/µl AmpErase UNG, 0.025 U/µl AmpliTaq Gold DNA polymerase, 200 nM each forward and reverse primer, 100 nM
TaqMan probe (Applied Biosystems), and 1 µl of RT product. The
reaction was performed in triplicate for each RT product. During the
extension phase of PCR, consisting of an initial denaturation step at
95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and
60°C for 1 min, the nucleolytic DNA polymerase cleaved the
hybridization probe, and the resulting relative increase in the
reporter fluorescent dye emission was monitored in real time using a
sequence detector (ABI prism 7700 sequence detector; Applied Biosystems). The fluorescent dye emission was a function of cycle number and was determined using the sequence detector software (Applied
Biosystems), giving the threshold cycle number
(CT) at which PCR amplification reached a
significant threshold. The value of the CT was
linearly correlated with logarithmic value of genomic DNA quantity.
|
| |
Results and Discussion |
|---|
|
|
|---|
Usually, the standard lines constructed gave good linearity with excellent correlation coefficients, with minimum day-to-day or within-a-day variation. Figure 1 shows the relative concentrations of MDR1, MRP1, MRP2, and CYP3A mRNA in Caco-2 cells, human duodenal enterocytes, normal colorectal tissue, and colorectal adenocarcinoma. The relative concentration of MDR1 mRNA in the Caco-2 cells was 1.00 ± 0.15 and was significantly lower than human duodenal enterocytes (11.89 ± 2.45) but comparable to normal colorectal tissue and colorectal adenocarcinoma (0.88 ± 0.33 and 0.60 ± 0.29, respectively). Caco-2 cells tended to have a lower level of MRP1 mRNA than human duodenal enterocytes, normal colorectal tissue, and colorectal adenocarcinoma (1.02 ± 0.06, 2.86 ± 2.36, 1.74 ± 0.76, and 1.65 ± 0.69, respectively). MRP2 mRNA level in Caco-2 cells was also lower than human duodenal enterocytes, but MRP2 mRNA was barely detectable in normal colorectal tissues and colorectal adenocarcinomas. Three of five Caco-2 cell lines had no detectable CYP3A mRNA, even after 40 cycles of PCR. CYP3A mRNA level in Caco-2 cells was extensively lower than human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas (0.68 ± 0.60, 5645.76 ± 1367.73, 27.27 ± 13.36, and 16.47 ± 8.17, respectively).
|
Real-time quantitative PCR method in which the amplification signals
are detected in real time has advantages over ordinary semiquantitative
methods based on densitometry involving a competitive PCR method and
Northern analysis, which contains a lengthy series of steps (mRNA
preparation, electrophoresis, blotting, hybridization, and
autoradiography) (Gibson et al., 1996
; Heid et al., 1996
; Yajima et
al., 1998
; Latil et al., 2000
). Besides, this method makes it
possible to quickly evaluate with high sensitivity the gene expression
profiles for numbers of target proteins, and therefore, it is useful as
a speedy assessment in advance of a functional analysis. In this
article, it was suggested that Caco-2 cells expressed only low levels
of MDR1, MRP1, MRP2, and CYP3A mRNA in comparison with human duodenal
enterocytes. CYP3A mRNA levels varied remarkably for Caco-2 cell lines,
suggesting that its content is susceptible to culture conditions. These
observations strongly suggested that considerable attention should be
paid to the transport data obtained from the Caco-2 cell system in
determining the overall absorption kinetics. It was also suggested that
the gene expression levels of these molecules in Caco-2 cells were
comparable with those in normal colorectal tissue and colorectal
adenocarcinoma, except for MRP2. Collectively, Caco-2 cell lines showed
the gene expression profiles of oral drug absorption-related proteins
closer to those of human normal colorectal tissue and adenocarcinoma rather than human duodenal enterocytes.
Tsutomu Nakamura
Toshiyuki Sakaeda
Nobuko Ohmoto
Takao Tamura
Nobuo Aoyama
Toshiro Shirakawa
Takashi Kamigaki
Takeshi Nakamura
Ke Ih Kim
Soo Ryang Kim
Yoshikazu Kuroda
Masafumi Matsuo
Masato Kasuga
Katsuhiko Okumura
Department of Hospital Pharmacy
(Ts.N, T.Sa., N.O., K.O.),
Second Department of Internal Medicine
(T.T., N.A., M.K),
First Department of Surgery
(T.K., Ta.N., Y.K.),
Department of
Urology (T.Sh.),
Departments of Clinical Genetics
and
International Center for
Medical Research (T.Sh., M.M.),
School of Medicine, Kobe University,
Kobe, Japan
Department of
Gastroenterology
(K.I.K., S.R.K.),
Kobe Asahi Hospital,
Kobe, Japan
| |
Acknowledgments |
|---|
We thank Dr. Ken-ichi Inui and collaborators at the Department of Pharmacy (Kyoto University Hospital, Faculty of Medicine, Kyoto University) for helpful discussions and critical comments on the draft of the manuscript. We thank Drs. Akira Tsuji and Ikumi Tamai of the Department of Pharmacobiodynamics (Faculty of Pharmaceutical Sciences, Kanazawa University), Dr. Mitsuru Hashida of the Department of Drug Delivery Research (Graduate School of Pharmaceutical Sciences, Kyoto University), Dr. Shinji Yamashita of the Department of Pharmaceutics (Faculty of Pharmaceutical Sciences, Setsunan University), Drs. Toshikiro Kimura and Kazutaka Higaki of the Department of Pharmaceutics (Faculty of Pharmaceutical Sciences, Okayama University), and Dr. S. Akira Yamamoto and Takuya Fujita of the Department of Biopharmaceutics and Biochemical Pharmacology (Kyoto Pharmaceutical University) for kindly supplying Caco-2 cells and helpful suggestions.
| |
Footnotes |
|---|
Received June 25, 2001; accepted October 16, 2001.
Prof. Katsuhiko Okumura, Ph.D., Department of Hospital Pharmacy, School of Medicine, Kobe University, Chuo-ku, Kobe 650-0017, Japan. E-mail: okumurak{at}kobe-u.ac.jp
| |
Abbreviations |
|---|
Abbreviations used are: MRP, multidrug resistance-associated protein; RT-PCR, reverse transcription-polymerase chain reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; CT, threshold cycle number.
| |
References |
|---|
|
|
|---|
,25-dihydroxyvitamin D3.
Mol Pharmacol
51:
741-754This article has been cited by other articles:
![]() |
K. May, K. Westphal, T. Giessmann, D. Wegner, U. Adam, M. M. Lerch, R. Oertel, R. W. Warzok, W. Weitschies, M. Braeter, et al. Disposition and Antimuscarinic Effects of the Urinary Bladder Spasmolytics Propiverine: Influence of Dosage Forms and Circadian-Time Rhythms J. Clin. Pharmacol., May 1, 2008; 48(5): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Lee, I-C. Ho, W.-J. Lu, and J.-d. Huang Enhanced Expression of Multidrug resistance-associated Protein 2 and Reduced Expression of Aquaglyceroporin 3 in an Arsenic-resistant Human Cell Line J. Biol. Chem., July 7, 2006; 281(27): 18401 - 18407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ludwig, G. Szakacs, S. E. Martin, B. F. Chu, C. Cardarelli, Z. E. Sauna, N. J. Caplen, H. M. Fales, S. V. Ambudkar, J. N. Weinstein, et al. Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer. Cancer Res., May 1, 2006; 66(9): 4808 - 4815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Imoto, H. Sakamoto, and M. Hashimoto IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION Drug Metab. Dispos., August 1, 2005; 33(8): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zimmermann, H. Gutmann, P. Hruz, J.-P. Gutzwiller, C. Beglinger, and J. Drewe MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT Drug Metab. Dispos., February 1, 2005; 33(2): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Michael and M.M. Doherty Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy J. Clin. Oncol., January 1, 2005; 23(1): 205 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. von Moltke, B. W. Granda, J. M. Grassi, M. D. Perloff, D. Vishnuvardhan, and D. J. Greenblatt INTERACTION OF TRIAZOLAM AND KETOCONAZOLE IN P-GLYCOPROTEIN-DEFICIENT MICE Drug Metab. Dispos., August 1, 2004; 32(8): 800 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C.-T. Ho, et al. Glucuronides of Tea Catechins: Enzymology of Biosynthesis and Biological Activities Drug Metab. Dispos., April 1, 2003; 31(4): 452 - 461. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||